Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (Africa)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (Africa)
UNAids is set to close in 2026 – four years early. Are experts right to be alarmed ?
20/10/2025
In Gaza, and now Ukraine, Donald Trump may be peace activists' greatest ally. That deserves our backing | Simon Jenkins
20/10/2025
The Beijing courier who went viral : how Hu Anyan wrote about delivering parcels – and became a bestseller
20/10/2025
Ange Postecoglou’s reputation has taken a hit that only time and the right move can restore
20/10/2025
Trump suggests carving up Ukraine’s Donbas region to end war after meeting with Zelenskyy
20/10/2025
Louvre museum robbery : how the thieves broke in, what they stole and what happens next
20/10/2025